Institutional investors purchased a net $467.5 thousand shares of ABIO during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 14.35% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SABBY CAPITAL LLC Bought 546.9 Thousand shares of ARCA Biopharma Inc
HABERER REGISTERED INVESTMENT AD... Sold 5.0 Thousand shares of ARCA Biopharma Inc